Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.
2.

An unseen danger: frequency of posterior vessel wall penetration by needles during attempts to place internal jugular vein central catheters using ultrasound guidance.

Theodore AC, Wilson KC.

Crit Care Med. 2010 Jan;38(1):345-6; author reply 346-7. doi: 10.1097/CCM.0b013e3181bfe76e. No abstract available.

PMID:
20023505
3.

Measurement of interleukin 16.

Center DM, Cruikshank WW, Parada NA, Ryan T, Theodore AC, Viglianti G, Lim KG, Weller PF.

Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.23. doi: 10.1002/0471142735.im0623s22.

PMID:
18432814
4.
6.

IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation.

Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, Center DM.

J Immunol. 1996 Dec 15;157(12):5240-8.

PMID:
8955168
7.

CD4 ligand IL-16 inhibits the mixed lymphocyte reaction.

Theodore AC, Center DM, Nicoll J, Fine G, Kornfeld H, Cruikshank WW.

J Immunol. 1996 Sep 1;157(5):1958-64.

PMID:
8757315
8.

The lymphocyte chemoattractant factor.

Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW.

J Lab Clin Med. 1995 Feb;125(2):167-72. Review.

PMID:
7844466
9.

Cytokine binding to CD4+ inflammatory cells: implications for asthma.

Center DM, Kornfeld H, Wu MJ, Falvo M, Theodore AC, Bernardo J, Berman JS, Cruikshank WW, Djukanovic R, Teran L, et al.

Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 2):S59-62. Review.

PMID:
7952594
10.
11.

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.

Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):5109-13.

12.

Mechanisms of lymphocyte accumulation in pulmonary disease.

Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW.

Chest. 1993 Feb;103(2 Suppl):88S-91S. Review. No abstract available.

PMID:
8094048
13.

Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes.

Cruikshank WW, Greenstein JL, Theodore AC, Center DM.

J Immunol. 1991 May 1;146(9):2928-34.

PMID:
1673145
14.

Lymphocyte recruitment to the lung.

Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM.

Am Rev Respir Dis. 1990 Jul;142(1):238-57. Review.

PMID:
2195933
15.

Lymphocyte motility and lymphocyte chemoattractant factors.

Berman JS, Cruikshank WW, Beer DJ, Kornfeld H, Bernardo J, Theodore AC, Center DM.

Immunol Invest. 1988 Nov-Dec;17(8-9):625-77. Review. No abstract available.

PMID:
3068125
16.

Lymphokine activation of T4+ T lymphocytes and monocytes.

Cruikshank WW, Berman JS, Theodore AC, Bernardo J, Center DM.

J Immunol. 1987 Jun 1;138(11):3817-23.

PMID:
3108375
17.

Pharmacotherapy of chronic obstructive pulmonary disease.

Theodore AC, Beer DJ.

Clin Chest Med. 1986 Dec;7(4):657-71. Review.

PMID:
2878760
18.

A human T-T-cell hybridoma-derived lymphocyte chemoattractant factor.

Theodore AC, Center DM, Cruikshank WW, Beer DJ.

Cell Immunol. 1986 Apr 1;98(2):411-21.

PMID:
3093096
19.

Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.

Berman JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ.

Cell Immunol. 1985 Oct 1;95(1):105-12.

PMID:
3161625
20.

Errant placement of nasoenteric tubes. A hazard in obtunded patients.

Theodore AC, Frank JA, Ende J, Snider GL, Beer DJ.

Chest. 1984 Dec;86(6):931-3.

PMID:
6499559

Supplemental Content

Loading ...
Support Center